Last reviewed · How we verify

NCT03787147: VR adult

Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI)

Withdrawn Phase 2 Last updated 14 January 2021
What this trial tests

Phase 2 trial testing Google Cardboard in Pain. Withdrawn.

Timeline
30 November 2020
Primary endpoint
1 December 2020
1 December 2020

Quick facts

Lead sponsorAlbert Einstein College of Medicine
PhasePhase 2
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Start date30 November 2020
Primary completion1 December 2020
Estimated completion1 December 2020

Drugs / interventions tested

Conditions studied

Sponsor

Albert Einstein College of Medicine

Who can join

18 and older, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A three-group parallel randomized controlled trial to evaluate the efficacy of virtual reality analgesia (VRA) to decrease patient procedural pain and anxiety in the Adult patients undergoing Spinal Injections (SI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Albert Einstein College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03787147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing